Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Pension (2016 - 2025)

Purple Biotech has reported Pension over the past 7 years, most recently at $145000.0 for Q4 2022.

  • Quarterly Pension fell 50.34% to $145000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $145000.0 through Dec 2022, down 50.34% year-over-year, with the annual reading at $145000.0 for FY2022, 50.34% down from the prior year.
  • Pension was $145000.0 for Q4 2022 at Purple Biotech, up from $144000.0 in the prior quarter.
  • Over five years, Pension peaked at $470000.0 in Q2 2018 and troughed at $144000.0 in Q3 2022.
  • The 5-year median for Pension is $265000.0 (2020), against an average of $277642.9.
  • Year-over-year, Pension grew 10.19% in 2021 and then plummeted 50.34% in 2022.
  • A 5-year view of Pension shows it stood at $405000.0 in 2018, then fell by 29.63% to $285000.0 in 2019, then fell by 7.02% to $265000.0 in 2020, then increased by 10.19% to $292000.0 in 2021, then plummeted by 50.34% to $145000.0 in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Pension are $145000.0 (Q4 2022), $144000.0 (Q3 2022), and $292000.0 (Q2 2022).